Amgen Inc.'s healthy commercial product portfolio and pipeline position the company well for long-term value creation. Read ...

Investing in solid dividend stocks can help navigate the uncertain economic environment we face. Regular payouts can help ...

Though Amgen AMGN and Viking Therapeutics VKTX do not currently market any obesity drugs, they are among the few biotechs that have shown immense potential in this space. Amgen boasts a strong ...

Amgen (AMGN) is eyeing the obesity drug race, currently dominated by Eli Lilly (LLY) and Novo Nordisk (NVO), with its two late-stage weight-loss drug trials. Citi Research managing director Geoff ...

First there were Victoza and Saxenda, then Ozempic seized the spotlight - followed by Wegovy and Mounjaro. And ever-better ...

Amgen Inc. (NASDAQ:AMGN) is one of the best drug stocks to buy right now. Amgen Inc. (NASDAQ:AMGN) reported its fiscal Q2 2025 earnings on August 5, with total revenues increasing 9% to $9.2 billion ...

Over the last four years, weight-loss drugs that dampen down appetite and promote satiety have revolutionised obesity medicine. They are currently being taken by 1.5 million people in the UK and have ...

Viking Therapeutics VKTX is one of the few biotech stocks that has shown immense potential in this space. It is developing VK2735, an investigational novel dual GLP-1 and GIP receptor agonist, in ...

Novo Nordisk (NASDAQ Copenhagen: NOVO-B) inflicted much pain—and much-needed pain—on the company when president and CEO Maziar (Mike) Doustdar announced plans to lay off about 9,000 of its 78,400 ...

Novo Nordisk NVO announced positive data from a sub-analysis of its phase III REDEFINE 1 study assessing the efficacy and safety of once-weekly cagrilintide 2.4 mg as a monotherapy, alongside ...

In this article, we will look at the 12 Best Drug Stocks to Buy Right Now. On September 10, FDA Commissioner Dr. Marty Makary appeared on CNBC’s ‘Squawk Box’ to talk about the agency’s crackdown on ...

The Fund lost value but held up significantly better than the Index during the quarter. Stock selection within biotechnology, pharmaceuticals, and life sciences tools & services, along with an ...